Alx1 is a conserved regulator of skeletogenesis in echinoderms and evolutionary changes in Alx1 sequence and expression have played a pivotal role in modifying programs of skeletogenesis within the phylum. Alx1 regulates a large suite of effector genes that control the morphogenetic behaviors and biomineral-forming activities of skeletogenic cells. To better understand the gene regulatory control of skeletogenesis by Alx1, we used genome-wide ChIP-seq to identify Alx1-binding sites and direct gene targets. Our analysis revealed that many terminal differentiation genes receive direct transcriptional inputs from Alx1. In addition, we found that intermediate transcription factors previously shown to be downstream of Alx1 all receive direct inputs from Alx1. Thus, Alx1 appears to regulate effector genes by indirect, as well as direct, mechanisms. We tested 23 high-confidence ChIP-seq peaks using GFP reporters and identified 18 active cisregulatory modules (CRMs); this represents a high success rate for CRM discovery. Detailed analysis of a representative CRM confirmed that a conserved, palindromic Alx1-binding site was essential for expression. Our work significantly advances our understanding of the gene regulatory circuitry that controls skeletogenesis in sea urchins and provides a framework for evolutionary studies.
INTRODUCTION
A central challenge of biology is to explain how morphology is encoded in the genome. The specification of distinct cell types and the subsequent organization of these cells into discrete anatomical structures are controlled by differential gene expression during embryonic development. As part of this process, networks of interacting regulatory (i.e. transcription factor-encoding) genes and signaling pathways, organized as modular gene regulatory networks (GRNs), control programs of gene expression in embryonic cells. Furthermore, there is considerable evidence that evolutionary changes in developmental GRNs that control anatomy have played a crucial role in morphological evolution (McGregor et al., 2007; Rebeiz and Tsiantis, 2017) . Currently, a major goal is to determine how different combinations of regulatory genes, functioning within a hierarchical network, regulate downstream effector genes to drive the morphogenesis of specific anatomical features during development.
The GRN that governs the development of the endoskeleton of the sea urchin embryo is one of the best-characterized developmental GRNs (reviewed by Shashikant et al., 2018a) . It is a valuable experimental model for dissecting the fine-structure of a GRN that controls the formation of a prominent anatomical structure and for elucidating the changes in a GRN that have contributed to morphological evolution. The embryonic skeleton of euechinoids is formed by a specialized group of skeletogenic cells known as primary mesenchyme cells (PMCs). These cells originate from large micromeres, four cells that arise near the vegetal pole during cleavage. The PMC GRN is activated in the large micromere territory through the combined action of maternal factors and unequal cell division (Oliveri et al., 2008; Shashikant et al., 2018a) . These maternal inputs activate early regulatory genes such as Alx1, Ets1 and Tbr (Ettensohn et al., 2003; Fuchikami et al., 2002; Kurokawa et al., 1999; Oliveri et al., 2002) , which engage downstream intermediate regulatory genes and subsequently several hundred terminal differentiation genes that govern PMC behavior and skeletal morphogenesis (Barsi et al., 2014; Oliveri et al., 2008; Rafiq et al., 2012 Rafiq et al., , 2014 .
The Paired-class homeodomain protein Alx1 plays a crucially important and evolutionarily conserved role in biomineralization throughout the phylum. Regardless of their larval forms, all adult echinoderms possess an extensive, calcitic endoskeleton. Owing to similarities between the GRNs of skeletogenic cells in the embryo and adult, it is widely thought that the embryonic skeleton arose via cooption of the adult skeletogenic program (Czarkwiani et al., 2013; Gao and Davidson, 2008; Gao et al., 2015; Killian et al., 2010; Richardson et al., 1989) . During euechinoid embryogenesis, expression of Alx1 can be detected as early as the 56-cell stage and is entirely restricted to the large micromere-PMC lineage (Ettensohn et al., 2003) . Perturbation of Alx1 function using antisense morpholinos dramatically inhibits PMC specification and skeletal morphogenesis (Ettensohn et al., 2003) . Conversely, over-expression of Alx1 results in ectopic activation of the skeletogenic program in other mesodermal cell lineages (Ettensohn et al., 2007) . Alx1 has positive inputs into almost half of the ∼400 genes known to be differentially expressed by the PMCs, highlighting its important role in establishing the unique identity of these cells (Rafiq et al., 2014) . In other echinoderm clades that form embryonic skeletons, Alx1 is expressed specifically by the skeletogenic lineage, where it is essential for biomineralization (Dylus et al., 2016; Erkenbrack and Davidson, 2015; Koga et al., 2016; McCauley et al., 2012; Rubinstein and de Souza, 2013) . Alx1 is also selectively expressed in the adult skeletogenic centers of sea urchins, brittle stars and sea stars (Czarkwiani et al., 2013; Gao and Davidson, 2008; Gao et al., 2015) . Ectopic expression of sea urchin or sea star Alx1 in sea star embryos, which lack an embryonic skeleton, is sufficient to activate several skeletogenic genes that have been reported to be downstream of Alx1 in sea urchins (Koga et al., 2016) . Recently, it was shown that the evolution of echinoderm biomineralization was associated with a gene duplication event that allowed Alx1 to evolve functions distinct from its paralog (Alx4/ Calx) through exonization of a novel 46-amino-acid motif (Khor and Ettensohn, 2017) . The neofunctionalization of Alx1 may have been associated with the evolution of regulatory linkages to new target genes with functions related to biomineralization.
In the present study, we performed genomic chromatin immunoprecipitation (ChIP-seq) to identify regions bound by Alx1 in euechinoid (Stronglycentrotus purpuratus) embryos. Our ChIPseq data reveal several thousand Alx1-binding sites throughout the genome. Our data show enrichment in Alx1-bound regions for binding sites associated with several potential co-regulators, including Ets1, Irx, Fos and Jun. Coupled with previously published ATAC-seq, DNase-seq and RNA-seq data (Rafiq et al., 2014; Shashikant et al., 2018b) , we determined that a large fraction of sea urchin skeletogenic terminal differentiation genes receive inputs from Alx1. We also found that many of the intermediate transcription factors differentially expressed by PMCs (e.g. Alx4, Dri, Fos, FoxB, Nfkbil1L and Nk7) receive direct inputs from Alx1. These findings demonstrate that Alx1 regulates many effector genes through direct, positive inputs, but also suggest that this direct regulation might operate in concert with inputs from intermediary transcription factors in a feed-forward fashion. Using GFP reporter assays, we examined 23 high-confidence ChIP-seq peaks and identified 18 active cisregulatory modules (CRMs), 15 of which selectively drive GFP expression in PMCs. Detailed analysis of one representative CRM located in an intron of Sp-EMI/TM, a gene that encodes a novel, PMC-specific protein, revealed a conserved, palindromic Alx1binding site that we found to be essential for expression. Electrophoretic mobility shift assay (EMSA) studies confirmed that recombinant Alx1 protein bound to this site. Taken as a whole, our study has identified hundreds of direct targets of Alx1 and revealed important features of the genetic network downstream of this pivotal regulator of echinoderm skeletogenesis. More generally, this work extends our understanding of an important, model developmental GRN and enhances its utility for evolutionary studies.
RESULTS

Sp-Alx1 antibody validation
Although Alx1 has an essential, evolutionarily conserved role in echinoderm skeletogenesis, there has been no genome-wide assessment of Alx1-binding sites or identification of direct targets of Alx1. Hence, we performed ChIP-seq to identify Sp-Alx1-binding sites using a custom, affinity-purified rabbit polyclonal antibody raised against a peptide contained within the D2 domain of Sp-Alx1 (Khor and Ettensohn, 2017) . We first validated the Sp-Alx1 antibody by western blotting using bacterially expressed, recombinant Alx1 (rAlx1) (Fig. S1A,B ). The antibody specifically recognized rAlx1 in induced bacterial cultures but not proteins in uninduced cultures and not rAlx4, a closely related homeodomain protein that lacks the D2 domain. The antibody also effectively immunoprecipitated rAlx1 from bacterial lysates ( Fig. S1C ). We further validated the Sp-Alx1 antibody using whole-mount immunofluorescence. As expected, the nuclei of PMCs were selectively labeled (Fig. S1D-F). Monoclonal antibody (mAb) 6a9, which recognizes PMC-specific cell surface proteins of the MSP130 family (Ettensohn and McClay, 1988; Illies et al., 2002) , was used as a marker for this cell type. In contrast, Sp-Alx1 morphant embryos, which lack PMCs, exhibited no Sp-Alx1 or mAb 6a9 staining ( Fig. S1G,H) .
Sp-Alx1 chromatin immunoprecipitation
ChIP-seq was performed using the validated Sp-Alx1 antibody and, for mock ChIP, normal rabbit IgG antibodies ( Fig. S2A ). We isolated crosslinked chromatin from mesenchyme blastula-stage embryos [∼24 hours post-fertilization (hpf )] from three independent fertilizations (see supplementary Materials and Methods). We chose this particular developmental stage because terminal differentiation genes downstream of Alx1 in the PMC GRN are expressed maximally at this stage, as determined by RNA-seq (Rafiq et al., 2014) . In addition, by using mesenchyme blastula-stage embryos it was possible to directly correlate our data with existing ATAC-seq and DNase-seq datasets derived from purified PMCs . Following immunoprecipitation, three Sp-Alx1 ChIP and three mock ChIP preparations were pooled separately and each was sequenced to a depth of approximately 20 million reads. After read quality control, alignment, and redundancy filtering, peaks that were enriched in the Sp-Alx1 ChIP sample compared with the nonspecific, mock ChIP control were identified from the remaining 8 million uniquely mapping reads from each sample ( Fig. S2B , see supplementary Materials and Methods). Using MACS2 with an mfold of [5, 50] and a P-value cutoff of 0.005, we identified 2906 peaks with an average length of 250 bp that were used for further analysis (Fig. S2C , Table S1 ).
ChIP-seq peak analysis
To remove potential false positives, the 2906 ChIP-seq peaks were first filtered to identify those that intersected by at least 1 nt with regions of accessible chromatin, which we defined as the union of the previously reported ATAC-seq and DNase-seq reference peak sets (RPSs) identified at the same developmental stage . The great majority of the Sp-Alx1 ChIP-seq peaks (2353/2906 peaks, or 81%) overlapped with regions of accessible chromatin, and this peak set was used for all further analyses. To corroborate the significance of this peak set, we first investigated whether such peaks were more likely to intersect with regions of chromatin that are differentially accessible in PMCs relative to non-PMC cells ('ATAC-seq or DNA-seq differential peaks'), regions that were previously identified as likely PMC enhancers (Fig. 1A ). We found that Sp-Alx1 ChIP-seq peaks were much more likely to overlap with ATAC-seq differential peaks than with ATAC-seq peaks as a whole (14.5-fold enrichment, hypergeometric P-value=1.14e −146 ). Similarly, Sp-Alx1 ChIP-seq peaks were far more likely to overlap with DNase-seq differential peaks than with DNase-seq peaks as a whole (14.8-fold enrichment, hypergeometric P-value=4.07e −313 ). Moreover, when considering the overlap between ATAC-seq and DNase-seq differential peaks, which consists of 168 peaks, these were much more likely to overlap with Sp-Alx1 ChIP-seq peaks than were other open regions of chromatin (32.0-fold enrichment, hypergeometric P-value=1.56e −84 ). Taken together, these findings confirmed that Sp-Alx1-binding sites were enriched in regions of accessible chromatin and showed that they were particularly enriched in regions selectively open in PMCs, supporting the view that these regions represent Alx1-bound regulatory elements active in PMCs.
Analysis of nearby genes
To associate Sp-Alx1 ChIP-seq peaks with putative gene targets, a peak-to-gene distance cutoff was required. We determined that most of the 2353 peaks (85%) were located within 20 kb of annotated genes ( Fig. 2A ). Furthermore, analysis of the location of the peaks relative to the closest genes revealed that 65% of the peaks were either in promoter regions (≤2 kb upstream) or within gene bodies ( Fig. 2B ). Moreover, 43% of peaks (1011 peaks) were found to be enriched near the 5′ ends of annotated genes, namely in the promoter regions and first introns. Closer inspection of the peaks located near transcription start sites (TSSs) showed that they were concentrated in the 5′ untranslated regions (5′ UTRs) and upstream of the TSSs (Fig. 2C,D) .
To evaluate further our choice of peak-to-gene distance, we investigated whether genes within 20 kb of Sp-Alx1 ChIP-seq peaks were enriched for genes that are sensitive to Alx1 morpholino (MO) and/or genes that are differentially expressed in PMCs , in line with our goal of associating peaks with putative direct target genes ( Fig. 1B ). We found that Alx1-MOsensitive genes were 3.0-fold (hypergeometric P-value=7.92e −51 ) more likely to have an Sp-Alx1 ChIP-seq peak located within 20 kb (22.3%), than were other annotated genes (7.5%). Similarly, genes differentially expressed by PMCs (which we refer to as PMC DE genes) were 6.4-fold (hypergeometric P-value=1.01e −115 ) more likely to have an Sp-Alx1 ChIP-seq peak located within 20 kb (48.1%), than were other annotated genes (7.5%). We observed that genes that met both criteria, i.e. DE genes that were also sensitive to Alx1 knockdown (which we refer to as Alx1 'functional targets') were 7.6-fold (hypergeometric P-value=3.27e −76 ) more likely to have an Sp-Alx1 ChIP-seq peak located within 20 kb (57.4%), than were other annotated genes (7.5%). Based on these observations, we decided on a 20 kb distance cutoff, which is well below the average sea urchin intergenic distance of ∼30 kb (Nam et al., 2010) . Although this cutoff is relatively conservative, we reasoned that it would minimize false positives and increase our confidence in associating Sp-Alx1 ChIP-seq peaks with direct target genes.
Gene Ontology (GO) term analysis of 1604 genes located within 20 kb of Sp-Alx1 ChIP-seq peaks revealed a substantial enrichment of genes with metalloendopeptidase inhibitor activity, DNA-binding transcription factor activity and GTPase-binding activity (Fig. S3A ). When using custom sea urchin-specific functional categories , we found a significant enrichment of genes associated with biomineralization, transcription factors and GTPase genes ( Fig. S3B ).
ChIP-seq peak motif enrichment analysis
To identify putative transcription factor-binding sites, including Alx1-binding sites, in our ChIP-seq peaks, we performed de novo motif enrichment analysis using DREME. An advantage of DREME is its ability to discover co-regulatory motifs in addition to the primary motif. Using our set of 2019 ChIP-seq peaks located within 20 kb of annotated genes, we found the most enriched motif to be one matching the Ets1 consensus sequence, followed by Alx1, Irx and Fos::Jun motifs (Fig. 3A ). Ets1 is a crucially important transcription factor in the PMC GRN that, together with Alx1, coregulates a large fraction of genes differentially expressed by PMCs (Kurokawa et al., 1999; Rafiq et al., 2014) . Fos and Jun are both expressed selectively by PMCs (Rafiq et al., 2012) , although their role in the network is not known. The developmental function of Irx has not been studied but this gene is expressed predominantly in the ectoderm (Chen et al., 2011; Howard-Ashby et al., 2006) . Using position weight matrices (PWMs) obtained from our DREME analysis, we performed a local enrichment analysis using CentriMo. We also included an Alx1 palindromic motif in our analysis. We observed that Ets1, Alx1 half-site and palindromic motifs tended to be located very close to peak summits, with the Alx1 motifs exhibiting the narrowest distribution ( Fig. 3A,B ). In contrast, Fos:: Jun heterodimer motifs displayed a broader region of enrichment and the Irx motif was not significantly enriched near peak summits ( Fig. 3A,C) .
To identify a high-confidence set of genes that are direct targets of Sp-Alx1, we integrated published gene expression and gene knockdown data with our ChIP-seq results (Fig. 4, Fig. S4A ) and found that 193 Sp-Alx1 ChIP-seq peaks were located within 20 kb of the 197 functional targets of Alx1 (Rafiq et al., 2014) . As genes can have multiple peaks around them, this corresponded to 114 genes, which we consider to be Alx1 direct targets (Table S2 ). Many of these direct targets exist in clusters within the S. purpuratus genome and have several Sp-Alx1 ChIP-seq peaks and ATAC-seq/ DNase-seq differential peaks located nearby (Fig. 5 ). Fig. 1 . Sp-Alx1 ChIP-seq peak enrichment analysis. (A) Proportion of peaks that intersect with differential peaks (by at least 1 nt) were compared with the proportion of peaks that intersect with reference peaks. Intensity of the bars corresponds to the significance of the enrichment, expressed as −log 10 (P-value). (B) Proportion of Alx1-MO-sensitive and/or PMC DE genes that have at least one Sp-Alx1 ChIP-seq peak within 20 kb were compared with the proportion of all annotated genes that have at least one Sp-Alx1 ChIP-seq peak within 20 kb.
MO knockdown studies have identified several regulatory genes that are downstream of Alx1 (Dri, Nfkbil1L, Fos, Alx4, Nk7 and FoxB) ( Fig. 6A) (Oliveri et al., 2008; Rafiq et al., 2014) . Although Sp-Dri and Sp-Fos were not identified as PMC DE genes in prior RNA-seq analysis (Rafiq et al., 2014) , whole-mount in situ hybridization studies showed that both genes are highly expressed in the PMCs at the mesenchyme blastula stage (∼24 hpf ) (Amore et al., 2003; Rafiq et al., 2012) . Remarkably, we found that all six regulatory genes have Sp-Alx1 ChIP-seq peaks within 20 kb, suggesting that they are regulated by Alx1 directly. To examine further the putative CRMs containing the Sp-Alx1 ChIP-seq peaks, we cloned these peaks and flanking non-coding sequences into reporter constructs (see Table S3 ) and injected them into fertilized eggs. We observed that CRMs associated with Sp-Alx4, Sp-Fos, Sp-FoxB and Sp-Nk7 were active in driving GFP expression ( Fig. 6B ). We observed variability among these CRMs with respect to both their levels of GFP expression and patterns of expression (Table 1) .
Many of our Sp-Alx1 ChIP-seq peaks were associated with genes that were not previously characterized as Alx1 functional targets (i.e. genes differentially expressed in PMCs and sensitive to Alx1 knockdown) (Rafiq et al., 2014) . In an attempt to identify Alx1 direct targets that may not have met this relatively stringent threshold, we focused on ChIP-seq peaks that overlapped (by at least 1 nt) regions of chromatin that were differentially accessible in PMCs relative to non-PMC cells (Fig. S2C ). Using this criterion, we identified 43 Sp-Alx1 ChIP-seq peaks that had not been flagged in our previous analyses ( Fig. S4B) . Surprisingly, among these we found Sp-Alx1 ChIP-seq peaks within the gene bodies of four regulatory genes (Sp-Ets1, Sp-Erg, Sp-Jun and Sp-Smad1/5/8) that are known to be expressed in the PMCs but have not been shown to be downstream of Alx1.
Validation of Alx1-binding regions and their utility for CRM discovery
To select a set of Sp-Alx1 ChIP-seq peaks to be tested by reporter gene assays, we focused on those that were associated with direct target genes, but added the criterion that peaks overlapped (by at least 1 nt) with regions of chromatin that were previously determined to be differentially accessible in PMCs relative to non-PMC cells (Fig. S4B , Table 2 ). All 25 such peaks were found to have putative Alx1 half-sites, of which many (16/25) are part of Alx1 palindromic sites. Most (20/25) also contained Ets1-binding sites (Fig. S4D ). We cloned these peaks and surrounding non-coding sequences into GFP reporter constructs (see Materials and Methods and Table S4 ). Remarkably, of the 23 putative CRMs tested (two of which contained a pair of adjacent Sp-Alx1 ChIP-seq peaks), 18 were active and drove GFP expression in PMCs (Fig. 7) . These CRMs varied with respect to level of GFP expression and the extent of ectopic (i.e. non-PMC) expression, but most (15/18) CRMs drove GFP expression selectively in PMCs (>64% PMC only) ( Table 3) . As sea urchin genes are generally controlled by multiple CRMs, our reporter constructs may not have included CRMs that contribute to the temporal and spatial expression patterns of these genes. Nevertheless, our in vivo reporter gene studies (1) strongly support the reliability of the Sp-Alx1 ChIP-seq data, (2) highlight the power of combining ChIP-seq, chromatin accessibility, and gene expression/knockdown data for CRM discovery, and (3) identify a large number of previously uncharacterized PMC CRMs that can now be characterized in detail.
Mutational and biochemical validation of Alx1-binding sites in a representative PMC CRM
To validate our Sp-Alx1 ChIP-seq data further, we carried out both mutational and EMSA analyses of a representative CRM identified through ChIP-seq. We chose an active, 522 bp CRM located near a novel PMC DE gene we call Sp-EMI/TM (WHL22.691495) (Fig. 8) . Alignment of the Sp-EMI/TM CRM with Lytechinus variegatus EMI/TM intronic sequences revealed that this region is highly conserved across >50 million years of evolution (Fig. S5A) .
Moreover, when injected into fertilized L. variegatus eggs, the Sp-EMI/TM CRM was able to drive PMC-specific GFP expression ( Fig. S5B) . Through deletion studies we found that a 139 bp fragment of the S. purpuratus CRM was sufficient to drive PMCspecific expression of GFP in S. purpuratus (Figs 8 and 9 ). The active 139 bp fragment contained one palindromic Alx1 site that was perfectly conserved in the two sea urchin species. Mutation of the conserved, palindromic site completely abolished GFP expression in transgenic embryos (Fig. 9A, Table 4 ). In addition, EMSA experiments confirmed that recombinant rAlx1 protein bound to a 30 bp, double-stranded DNA probe that included the wild-type palindromic site (Fig. 9B ). The binding of rAlx1 was abolished, however, when mutations were introduced into the palindromic site. Thus, our in in vivo reporter and EMSA studies demonstrate that Alx1 binds directly to the palindromic site and that binding is required for the transcriptional activity of the 139 bp Sp-EMI/TM CRM.
DISCUSSION
Architecture of the skeletogenic GRN
It has been proposed that sea urchins, nematodes, ascidians and several other animal groups develop by a 'Type I' mechanism (2) and Irx. Motif probability curves were smoothed according to weighted moving average of 80 bp. (Davidson, 2006) . According to this view, Type I development is characterized by the early (pre-gastrula stage) embryonic expression of terminal effector genes. A cardinal prediction that follows from these expression patterns is that the developmental GRNs that control the expression of differentiation genes in Type I embryos are relatively shallow; i.e. there are relatively few regulatory layers interposed between cell specification and effector gene activation. In euechinoid sea urchins, Alx1 is activated in the founder cells of the PMC lineage (the large micromeres) in the first cell cycle after they are born, through the activity of maternal factors and zygotically expressed Pmar1 (Ettensohn et al., 2003; Oliveri et al., 2003) . Our findings reveal that Alx1 provides positive transcriptional inputs into many effector genes, revealing a direct linkage between cell specification and effector gene expression. At the same time, however, Alx1 provides direct inputs into several regulatory genes, as described below. The transcription factors encoded by these regulatory genes may control targets that are completely distinct from those of Alx1, or they may cooperate with Alx1 to regulate common effector genes by a feed-forward mechanism. To clarify the topology of the network, it will be necessary to identify the targets of the regulatory genes downstream of Alx1 and analyze the cis-regulatory control of those effector genes.
Linking a GRN to morphogenesis
Morphogenesis is the product of hundreds of specialized proteins that directly regulate cell movement, cell adhesion, cell proliferation, and other cell behaviors that shape embryonic tissues. Developmental GRNs, including the PMC GRN, determine which genes are active or inactive in each spatiotemporal domain of the embryo. Linking developmental GRNs to effector genes that control morphogenesis is therefore essential for elucidating the connection between genotype and phenotype. Our current understanding of the architecture of the sea urchin skeletogenic GRN has been deduced primarily (although not exclusively) from gene knockdown and gene expression studies, which provide important information concerning functional gene regulatory interactions but do not reveal whether such interactions are direct or indirect. To link the skeletogenic GRN (or other GRNs) to morphogenesis, there is a need to identify the cis-regulatory elements of genes that control developmental anatomy and elucidate their direct transcriptional inputs (Wang et al., 2019) .
Intermediate network architecture
To improve our understanding of intermediate layers of regulatory control within the PMC GRN hierarchy, we searched for regulatory genes that are likely to be directly controlled by Alx1. There are 404 S. purpuratus genes that have been annotated as transcription factors and a significant subset of these (59/404, or 15%) have Alx1binding sites nearby (<20 kb). Six regulatory genes (Alx4, Dri, Fos, FoxB, Nfkbi1L and Nk7) were previously shown to receive positive inputs from Alx1 (Rafiq et al., 2014) and we found that all six genes have Alx1-binding sites nearby, consistent with the view that Alx1 regulates these genes directly. Validation of these ChIP-seq peaks revealed active CRMs near Sp-Alx4, Sp-Fos, Sp-FoxB and Sp-Nk7 (Fig. 6) . Only the Sp-Nk7 CRM, however, drove GFP expression selectively in PMCs. This is not unexpected, as regulatory genes Fig. 4 . Integration of ChIP-seq and RNA-seq data to identify direct Sp-Alx1 targets. Scatterplot shows fold change of transcripts from PMCs versus other cells plotted against fold change of transcripts from control versus Sp-Alx1 morphants, as reported by Rafiq et al. (2014) . Points with black outline represent Sp-Alx1 'functional target genes' i.e. genes that are Alx1-MO-sensitive and differentially expressed in PMCs (PMC DE genes). Points with black outline that are colored red represent genes with at least one Sp-Alx1 ChIP-seq peak within 20 kb. Intensity of the red color corresponds to the significance of the associated peak, expressed as −log 10 (P-value). Several genes of interest are labeled.
often have complex expression patterns and cis-regulatory architectures. The Alx1-bound CRMs we identified may lack binding sites for tissue-specific repressors or contain binding sites for activators that normally drive expression in non-skeletogenic tissues. For example, Sp-FoxB is strongly expressed in PMCs at 24 hpf but at later stages is expressed in the oral ectoderm and oral endoderm (Minokawa et al., 2004) . At the stage we assessed GFP expression (48 hpf ), the pattern of reporter gene expression closely resembled the endogenous expression pattern of Sp-FoxB.
Surprisingly, we also found evidence of direct Alx1 inputs into several regulatory genes that have not previously been considered Alx1 targets. These include known components of the skeletogenic GRN: Sp-Ets1, Sp-Erg, Sp-Jun and Sp-Smad1/5/8. A possible input from Alx1 into Ets1 is of special interest as the reverse regulatory relationship has been proposed, i.e. it has been suggested that zygotic Ets1 is the primary activator of Alx1 (Damle and Davidson, 2011) . We hypothesize that, instead, Alx1 activates Ets1 and establishes a positive-feedback loop whereby Ets1 maintains Alx1 expression, consistent with data reported by Oliveri et al. (2008) and Sharma and Ettensohn (2010) . The placement of Alx1 upstream of Ets1 and other regulatory genes is consistent with high-resolution NanoString data showing that zygotic expression of Sp-Alx1 precedes that of Sp-Ets1 and Sp-Erg by several hours (K. Rafiq and C.A.E., unpublished observations) . In previous studies (Oliveri et al., 2008; Rafiq et al., 2014) , decreases in the levels of Ets1, Erg and Smad1/5/8 mRNAs in PMCs following Alx1 knockdown may have been obscured by the presence of these mRNAs in cell types other than the PMCs (Lapraz et al., 2009; Rizzo et al., 2006) . Furthermore, building upon previous observations of repression between competing GRNs (Oliveri et al., 2008 ; and see below) we hypothesize that, in Alx1 morphants, activation of an alternative, non-skeletogenic mesoderm (NSM)-like GRN in the large micromere-PMC territory may have elevated expression of genes like Ets1 and Erg by an Alx1-independent pathway. In summary, our findings point to several new regulatory relationships within the PMC GRN that can now be explored in detail.
Terminal effector gene targets of Alx1
A previous study showed that Alx1 positively regulates ∼50% of effector genes selectively expressed by PMCs, and an even larger fraction of the effector genes that are expressed at high levels (Rafiq et al., 2014) . Surprisingly, we have found that most of these gene regulatory interactions (114/194 or 58%) appear to involve direct inputs from Alx1. Genes that are regulated directly by Alx1 have a diverse repertoire of functions, including matrix remodeling, PMC fusion, and biomineralization. For example, there are 12 sea urchin tissue inhibitor of metalloproteinases (TIMP) genes (Angerer et al., 2006 ). Ten of these TIMP genes are tandemly arranged in a single cluster and seven have Sp-Alx1 ChIP-seq peaks within 20 kb of the gene. Although their function in the sea urchin embryo is not known, TIMPs have been implicated in regulation of the function of matrix metalloproteases (MMPs) in other systems (reviewed by Brew and Nagase, 2010) . There are nearly 240 metalloprotease genes in the sea urchin genome (Angerer et al., 2006) and metalloprotease inhibitors reversibly block spiculogenesis by PMCs in vivo and in vitro (Ingersoll and Wilt, 1996; Roe et al., 1989) . We found that that 20 of the metalloprotease genes have Sp-Alx1 ChIP-seq peaks nearby, of which five had been shown previously to be downstream of Alx1 (Sp-Anpep1, Sp-CbpdEL, Sp-Mmp16, Sp-Mtmmpb and Sp-Mtmmpd) (Rafiq et al., 2014) . Four of the Alx1-regulated , strongly suggesting that the interactions are direct. Other terminal differentiation genes directly regulated by Alx1 include members of several well-characterized families of biomineralization-related genes. These include the MSP130 gene family, the spicule matrix/C-lectin domain gene family and the P16 gene family. Specifically, likely direct targets of Alx1 include five MSP130 genes (Sp-Msp130, Sp-Msp130r1, Sp-Msp130r2, Sp-Msp130r3 and Sp-Msp130r3_1), eight spicule matrix/C-lectin domain genes (Sp-Clect, Sp-Clect_13/Sp-Sm21, Sp-Clect_14/Sp-Sm20, Sp-Clect_25, Sp-C-lectin, Sp-C-lectin/PMC1/Sp-Sm49, Sp-Sm29 and Sp-Sm30E) and three P16 genes (Sp-P16, Sp-P16r1 and Sp-P16r2). We also determined that Alx1 directly targets two Ig-domain genes, SpKirrelL and Sp-Kirrel2L, one of which (Sp-KirrelL) is required for PMC fusion (Ettensohn and Dey, 2017) .
Remarkably, we found that Alx1 targets also include important, PMC-specific signaling receptors that play crucial roles in PMC guidance, migration and patterning. For example, we found that Alx1 provides direct transcriptional inputs into a VEGF receptor (Sp-Vefgr-Ig10) (Adomako-Ankomah and Ettensohn, 2013; Duloquin et al., 2007) , an FGF receptor (Sp-Fgfr2_1) (Lapraz et al., 2006) and a TGFβ receptor (Sp-Tgfbr2) (Sun and Ettensohn, 2017) . Taken together, direct Alx1 targets define a genetic subcircuit that impinges on almost all aspects of PMC behavior, including migration, fusion and biomineralization.
Co-regulation of effector genes by Alx1 and Ets1
Ets1 knockdown or the over-expression of a dominant-negative form of Ets1 inhibit PMC ingression and specification, effects that are also seen following Alx1 knockdown (Ettensohn et al., 2003; Kurokawa et al., 1999) . Out of 170 genes regulated by Ets1, 85% showed significant decreases in expression in Alx1 morphants (Rafiq et al., 2014) . This striking, overlapping regulatory control over downstream effector genes by Alx1 and Ets1 has not been fully elucidated. It has been proposed that Ets1 and Alx1 might regulate effector genes via a feedforward mechanism, whereby Ets1 positively regulates Alx1 and both regulatory inputs are required to drive the expression of downstream genes (Ets1→Alx1, Ets1+Alx1→effector) (Oliveri et al., 2008) . Our observation that consensus Ets1-binding sites are highly enriched in Alx1 ChIP-seq peaks provides strong evidence in support of this hypothesis and suggests that such a mechanism operates to regulate the expression of a large fraction of effector genes. We found that 136/192 (70.8%) peaks near Alx1 direct targets and 20/25 (80.0%) high-confidence peaks had consensus Ets1-binding sites, in addition to Alx1 half or palindromic sites, consistent with previous studies showing enrichment of both Alx1 and Ets1 sites in regions differentially open in the PMCs (Fig. S4C,D) .
Competition between GRNs: the role of Alx1 in excluding alternative regulatory states Oliveri et al. (2008) found that, in addition to its role as an activator of the PMC regulatory program, Alx1 prevents the deployment of the pigment cell GRN in the large micromere territory. Rafiq et al. (2014) provided evidence that this exclusionary function of Alx1 extends to other non-skeletogenic, mesodermal gene regulatory programs. The molecular mechanisms that might account for such an exclusionary function, and for competition between GRNs more generally, are of great interest but are presently unknown. In our analysis, we identified Sp-Alx1 ChIP-seq peaks near regulatory genes that are upregulated in Alx1 morphant embryos at 28-30 hpf (Sp-Scl, Sp-Irf4, Sp-Z166 and Sp-Nr4a) (Rafiq et al., 2014) . Sp-Scl is specifically expressed in oral non-skeletogenic mesoderm cells at this stage, although expression is detected in PMCs at 48 hpf (Solek et al., 2013) . Notably, we identified an intronic ChIP-seq peak within Sp-Scl at a location previously shown to be differentially accessible in PMCs, both in ATAC-seq and DNase-seq data . At present, we cannot distinguish whether the function of this Alx1 input is to repress Sp-Scl in PMCs at the mesenchyme blastula stage or to prime the gene for activation at later developmental stages. Sp-Z166 and Sp-Irf4, in contrast, are expressed specifically by presumptive pigment cells (Materna et al., 2013) and blastocoelar cells (J.M.K. and C.A.E., unpublished observations), respectively. Our findings support the view that Alx1 provides direct, negative inputs into these NSM regulatory genes that prevent their deployment in presumptive PMCs. Our previous study provided evidence of a trans-regulatory change, specifically a gene duplication event that permitted the functional specialization of the Alx1 protein through changes in the exon-intron organization of Alx1 (Khor and Ettensohn, 2017) . We found that the gain of a small, novel domain (the D2 domain) imparted new functions to Alx1 and supported the evolution of skeletogenesis in echinoderms. In our present study, we provide evidence that a large part of the sea urchin skeletogenic GRN is directly controlled by Alx1, including terminal differentiation genes that are expressed in adult skeletogenic centers, such as the spicule matrix and MSP130 genes. Hence, we hypothesize that evolutionary changes in the amino acid sequence of Alx1 that allowed it to acquire new targets preceded cis-regulatory changes in the Alx1 gene that resulted in its embryonic expression. Consistent with observations by Koga et al. (2016) , a heterochronic shift in Alx1 expression from adult skeletogenic centers to PMCs may have been sufficient to directly activate a large cohort of biomineralization genes and transfer skeletogenesis into the embryo.
MATERIALS AND METHODS
Animals
Adult Strongylocentrotus purpuratus were acquired from Patrick Leahy (California Institute of Technology, USA). Gamete release was induced by intracoelomic injection of 0.5 M KCl and fertilized embryos were cultured in artificial seawater at 15°C in temperature-controlled incubators. The region of overlap between the ChIP-seq peak, ATAC-seq differential peak, and DNase-seq differential peak was cloned into a reporter construct for detailed analysis. (C) Schematic of the 522 bp CRM. Position of putative Alx1-binding sites are represented by purple circles. Crosses indicate mutated binding sites. Constructs in dark green represent active CRMs that supported strong, PMC-specific GFP expression. Constructs in light green represent CRMs that supported weak, PMC-specific GFP expression. Constructs in pink represent CRMs that were not active.
Morpholino injections
Microinjection of MOs (Gene Tools) into fertilized eggs was performed as described (Cheers and Ettensohn, 2004) . The translation-blocking Sp-Alx1 MO was complementary to the 5′ UTR and had the sequence 5′-TATTGAGTTAAGTCTCGGCACGACA-3′. This MO has been characterized in previous studies (Ettensohn et al., 2003; Rafiq et al., 2014) . MO injection solutions contained 4 mM Sp-Alx1 MO, 20% glycerol (vol/vol) and 0.1% rhodamine dextran (wt/vol).
Sp-Alx1 antibody immunofluorescence staining
Custom affinity-purified rabbit polyclonal Sp-Alx1 antibody was produced by Biomatik (Cambridge, Ontario, Canada) using the following chemically synthesized peptide as immunogen: QPPAPVEGAMLRICRNLQNLRRE-FDSRK. This peptide sequence is contained within a region unique to Alx1 known as the D2 domain (Khor and Ettensohn, 2017) . The antibody was validated in control embryos and Sp-Alx1 morphants by double immunofluorescence staining with a monoclonal antibody (mAb) 6a9, which recognizes PMC-specific cell surface proteins of the MSP130 family (Ettensohn and McClay, 1988) . Control embryos and Sp-Alx1 morphants were collected and transferred to round-bottom 96-well plates for fixation and staining, as described (Khor and Ettensohn, 2017) . The embryos were doublestained with mAb 6a9 tissue culture supernatant and Sp-Alx1 antibody and counterstained with Hoechst dye (see supplementary Materials and Methods). Mounted embryos were imaged using a Zeiss LSM 880 confocal microscope. Fig. 9 . Experimental validation of Alx1 palindromic binding to the Sp-EMI/TM CRM. (A) GFP expression in PMCs, driven by different truncations and site-specific mutations of the Sp-EMI/TM CRM (see Fig. 8 ). (B) EMSA showing association of rAlx1 with double-stranded DNA containing the wild-type Alx1 palindromic binding site, which was abolished when the binding site was mutated. Scale bar: 50 µm. 
